Dear Mr. Gil Sharell,
a view Questions before investing more in EPCG:
With such a significant drop in share price this year and the loss of $xxxxx in market
capitalization, what is the company’s strategic plan to regain those losses?
What specific steps is the company planning to take?
What actions is the company taking to improve investor confidence and the stock’s
performance?
What percentage of stock is held by institutional investors?
By management and board members? By employees?
Does the company monitor trading by board members, officers, and others in management?
What percent of the company's shares is held in nominee or "street" name, or by foreign investors?
Who are the largest shareholders (including beneficial interests)?
Have executives or directors bought the company's stock in the open market?
If not, why?
Explain the reason for the significant sales of company stock.
In light of subsequent declines in the company’s stock price, were these sales based on insider information not
available to all shareholders?
Are any venture capital firms represented on the board?
Are their interests different from those of other shareholders?
How much dilution of common stock could occur as a result of the exercise of options issued
under the company's stock option plan (e.g., if all outstanding awards would be exercised)?
Is the company proposing a new compensation plan that could lead to significant dilution?
How much is the company’s options “overhang,” that is, existing and available options as a
percentage of shares outstanding?
How does the company limit potential dilution caused by options?
If the company does this by repurchasing its shares, what percentage of the company’s cash flow is used for this purpose?
lets see what happens...
waiting for a response.
things are changing.
alpha omikron
